Emirati Genome Programme partners with SEHA to increase participation in Abu Dhabi

Emirati Genome Programme partners with SEHA to increase participation in Abu Dhabi

The Emirati Genome Programme announced its collaboration with SEHA (Abu Dhabi Health Services Co.) to increase Emirati citizens' participation. As part of the partnership, SEHA hosted a three-day sample collection event for their Emirati employees. In partnership with SEHA's network of care facilities, new sample collection sites have been added in Abu Dhabi, which include Al Zafaranah Diagnostic & Screening Center, Sheikh Khalifa Medical City, Corniche Hospital, Madinat Khalifa Healthcare Center, and Baniyas Healthcare Center. Additionally, in Al Ain, new centers have been set up in Tawam Hospital and Mezyad Healthcare Center. Dr Anwar Sallam, group chief medical officer, SEHA, said: "We share the vision of a comprehensive healthcare system in the UAE that is more personalized, and one which will significantly improve disease prevention, diagnosis, and treatment. At SEHA, we have already seen a great level of participation by our Emirati employees. This partnership will further provide easier access and attract more participants to the programme. We call upon all Emiratis to participate in the world's largest genomic studies, as their contribution will pave the way towards a healthier future for generations to come." G42 Healthcare will utilise its Biogenix Labs – Omics Centre of Excellence to analyse